Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Home
Menu
JOIN
SI Premium
Ratings
Mergers
Earnings
Dividends
IPOs
Hedge Funds
Premium Letters
Send a Tip
API/Data
JOIN
SI Premium
Full Feed View
Headline View
SI Premium Squawk Box
Alerts
Custom Headlines
Upgrade Your Current Account
API
Calendars
Co. NDR/Event Calendar
Dividend Calendar
Earnings Calendar
Event Driven
FDA Calendar
Investor Conferences
IPO Calendar
Merger Arb
Ratings Calendar
Stock Split Calendar
Ratings
Analyst Comments
Hot Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades
New Coverage News
Hot New Coverage
Upgrade News
Hot Upgrades
More...
Mergers
Merger News
Hot M&A News
Private Equity
Rumors
SPAC News
Spinoffs
Merger Arbitrage
Event Driven
2021 Top M&A Deals
Top 50 Takeover Targets
More...
Earnings
Earnings Calendar
Earnings News
Hot Earnings
Guidance
Hot Guidance
Conference Calls
Earnings History Search
More...
Dividends
Dividend Calendar
Dividend News
Hot Dividends
Dividend Hike
Special Dividends
Stock Buybacks
Hot Stock Buybacks
Stock Splits
More...
IPOs
IPO News
Hot IPOs
Equity Offerings
Recent IPOs
Upcoming IPOs
2021 Top IPOs
More...
Hedge Funds
13D
13F
13G
Hedge Funds News
Hot Insider Trades
Insider Trades
More...
Premium Letters
Pulse Picks
Stealth Growth Insider
Send a Tip
API/Data
QUICK LINKS :
Goldman Sachs Conviction Buy List
Warren Buffett News
Elliott Management News
Follow @Street_Insider
Sucampo Pharmaceuticals, Inc. (SCMP) Tops Q2 EPS by 1c; Updates FY14 GAAP EPS Outlook
Article
Related Press Releases (
2
)
Related SEC Filings (
1
)
Stock Quotes (1)
FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
StreetInsider.com Top Tickers, 8/12/2026
1.
CRWV
2.
SMCI
3.
LITE
4.
ONON
5.
CAVA
6.
AMC
7.
NCMI
8.
FOCL
9.
TME
10.
CNK
Top News
Most Read
Special Reports
Wall St futures tick up heading into July inflation data
Oil rises after attacks on ships in Hormuz, Bab el-Mandeb
S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
Goldman Sachs warns AI investment may be crowding out other business spending
Why Wednesday's inflation print could provide the next dovish catalyst
Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
Wall Street ends down as US-Iran peace optimism fades
Comscore plans restructuring with $20M-$25M in cost cuts
After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Go back to Sucampo Pharmaceuticals, Inc. (SCMP) Tops Q2 EPS by 1c; Updates FY14 GAAP EPS Outlook
Form 8-K Sucampo Pharmaceuticals, For: Aug 05
August 5, 2014 6:20 AM EDT
http://archive.fast-edgar.com/20140805/AW2X962CZ22EWZW2222B2ZD2OUWHZZ22X262
Filed on: August 5, 2014...
More
